InvestorsHub Logo

TOB

Followers 162
Posts 5764
Boards Moderated 1
Alias Born 09/15/2010

TOB

Re: None

Thursday, 06/19/2014 6:22:19 PM

Thursday, June 19, 2014 6:22:19 PM

Post# of 689199
Unfortunately MD Anderson has in fact rebuked NWBO

Jim Newman, a spokesman for M.D. Anderson, said Northwest Biotherapeutics had released bits and pieces of data from the ongoing trial in a series of recent press releases that had the potential to provide an inaccurate picture of results from the Phase I/II study.



I had hoped it would have remained a misleading title by Adam Feuerstein that should have read "A leading Doctor at prestigious Cancer Hospital Rebukes..."

But now it's official.

IMO, if MD Anderson received a flurry of angry emails and phone calls from irate investors, this would have necessitated MD Anderson releasing this statement making official Dr Buzdar's observations.

No way would they tolerate an eminent doctor on their staff being attacked. Dr Buzdar is a tenured professor and vice-president of clinical research in the world's leading cancer research hospital.

An "own goal" by investors, as we say in football.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News